Generation of Haploid Stem Cells From Human Germ Cells

December 10, 2013 updated by: Rambam Health Care Campus
Human cells are diploid (contain a double set of chromosomes). The diploid genome is complex and therefore limits genetic research approaches in biomedical models. To overcome this problem experimental generation of haploid stem cells has been done in animals. The investigators aim at generating haploid stem cells from human germ cells that are a useful tool in genetic research and screening.

Study Overview

Status

Unknown

Intervention / Treatment

Detailed Description

Human cells are diploid (contain a double set of chromosomes). The diploid genome is complex and therefore limits genetic research approaches in biomedical models. To overcome this problem experimental generation of haploid stem cells has been done in animal models. haploid cells are easier for genetic manipulations, such as knock-in and knock-out of genes, and therefore should make a better experimental model. The investigators aim at generating haploid stem cells from human haploid germ cells.

Study Type

Observational

Enrollment (Anticipated)

10

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Haifa, Israel, 30196
        • Not yet recruiting
        • Rambam Medical Center
        • Contact:
        • Principal Investigator:
          • Itay Maza, MD
      • Rehovot, Israel, 76100
        • Recruiting
        • Weizmann Institute of Science
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 50 years (Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

Male

Sampling Method

Non-Probability Sample

Study Population

Male volunteers

Description

Inclusion Criteria:

  1. males over the age of 18 and under 50
  2. no known chronic illness
  3. not taking any chronic drugs

Exclusion Criteria:

  1. females
  2. males under 18 or over 50
  3. any known chronic illness
  4. taking chronic medications

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Sperm sample from healthy volunteers
Collected germ cells will be cultured in medium. The germ cell cultures will be infected with reprograming factors. Rare colonies with characteristic stem cell morphologies will be expanded.
Other Names:
  • generation of stem cells from somatic haploid germ cells

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Patients donated samples
Time Frame: June 2011-November 2013
No samples collected to date
June 2011-November 2013

Secondary Outcome Measures

Outcome Measure
Time Frame
No secomdary outcome
Time Frame: June 2011 - November 2013
June 2011 - November 2013

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Itay Maza, M.D, Rambam Health Care Campus

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

December 1, 2011

Primary Completion (Anticipated)

December 1, 2014

Study Completion (Anticipated)

August 1, 2015

Study Registration Dates

First Submitted

October 16, 2011

First Submitted That Met QC Criteria

October 18, 2011

First Posted (Estimate)

October 19, 2011

Study Record Updates

Last Update Posted (Estimate)

December 11, 2013

Last Update Submitted That Met QC Criteria

December 10, 2013

Last Verified

December 1, 2013

More Information

Terms related to this study

Other Study ID Numbers

  • rmb-maza0001-ctil

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Induced Pluripotent Stem Cells

Clinical Trials on generation of stem cells

Subscribe